NCT02656420View on ClinicalTrials.gov

Broccoli Sprout Dose Response: Bioavailability and Effects of Air Pollutants

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Environmental Carcinogenesis
Interventions
DRUG

Broccoli Sprout-derived Beverage

Maximum, half and one-fifth doses of broccoli sprout-derived beverage compared to placebos.

DRUG

Placebos

Placebo as comparison to broccoli sprout-derived beverages

Trial Locations (1)

226200

Qidong Liver Cancer Institute, Qidong

All Listed Sponsors
collaborator

Qidong Liver Cancer Institute

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT02656420 - Broccoli Sprout Dose Response: Bioavailability and Effects of Air Pollutants | Biotech Hunter | Biotech Hunter